Projecten
Controlled Organoids transplantation as enabler for regenerative medicine translation’ — ‘ORGANTRANS’ Vlaams Instituut voor Biotechnologie
A Comprehensive Translational Research and Training Pipeline Harnessing Lipid Metabolism to Improve Prostate Cancer Management and Educate Young Researchers in Tackling Complex Disease KU Leuven
In the face of complex multifactorial diseases, such as cancer, and the challenges posed by our aging society, the translation of technological advancements into personalised and cost-effective treatments remains a pressing concern for the scientific community. With the support of the Marie Skłodowska-Curie Actions, the PROSTAMET project will create an immersive Doctoral Network (DN) dedicated to training the next generation of researchers in ...
To strengthen the R&D capacities of the Institute of Tropical Medicine Alexander von Humboldt (Peru) to deliver strategies and/or tools for diagnosis, surveillance and control of infectious diseases. Instituut voor Tropische Geneeskunde
Translationele SYStemics: gepersonaliseerde geneeskunde op het raakvlak van translationeel onderzoek en systeemgeneeskunde KU Leuven
TranSYS will recruit 15 ESRs to highly skilled jobs in the new area of Systems Health developing tools and approaches to exploit large and complex datasets, to advance Precision (Personalised) Medicine in several disease areas. The training programme and experience of different international research environments cuts across traditional data and life sciences silos. The emphasis on translational research will support new collaborations ...
Klinische vertaling versnellen. In kaart brengen van de vertalingspolitiek in de Europese Unie KU Leuven
In the post–genomic era, innovation policies in biomedicine are increasingly being driven by the notion that constant advancements in biological knowledge fail to materialize into tangible therapeutic outcomes. Discursively framed in terms of a “gap” between “bench” and “bedside” in need of urgent “bridging”, this representation of the shortcomings of biomedical innovation has propelled growing efforts tailored towards the clinical ...
De complexiteit van de melanomen benutten om tegemoet te komen aan de Europese behoeften aan onderzoekstraining in de biologie van translationele kankerstelsels en de geneeskunde voor kankersystemen. KU Leuven
Novel treatment options and associated personalised, patient-tailored therapies need to be explored and developed for highly heterogeneous and chemotherapy resistant cancers, such as malignant melanoma. This can only be achieved by industry-academia collaborations in newly emerging, innovative research disciplines such as translational cancer systems biology and systems medicine. These disciplines and the associated European training needs ...
Innovatief trainingsnetwerk: Immunoprofielgestuurde stratificatie van patiënten met de auto-immuunziekte trombotische trombocytopenische purpura KU Leuven
The PROFILE Innovative European Industrial Doctoral programme will develop improved tools for stratification of patients with the autoimmune disorder acquired thrombotic thrombocytopenic purpura (TTP). Patient stratification is needed in order to further develop personalized medicine approaches for human disorders. Therefore, a detailed understanding of the disease at the molecular level is needed. Furthermore, implementation of a robust set ...
Training van de volgende generatie Europese glioblastoma (translationele) onderzoekers, om nauwkeurige targeting van de micro-omgeving van de hersentumor op te lossen KU Leuven
Isocitrate dehydrogenase wildtype (IDHwt) glioblastoma (GBM) is the most frequent, aggressive and lethal brain tumour. It has a universally fatal prognosis with 85% of patients dying within two years. Effective precision medicine therapies are thus urgently required. This can only be achieved by focused multi-sectoral collaborations in innovative research disciplines. Overall, GLIORESOLVE will exploit the intractability of GBM to address ...
De menselijke genetische en immunologische determinanten van de klinische manifestaties van SARS-CoV-2-infectie: op weg naar gepersonaliseerde geneeskunde KU Leuven
The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variability is the key scientific and medical enigma in the field. While age and certain co-morbidities are known to influence disease outcome, these parameters do not explain all variation. In addition, there are other SARS-CoV-2 phenotypes of clinical importance: multisystem inflammatory syndrome in children and ...